Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Return on Sales (2016 - 2025)

Marimed (MRMD) has disclosed Return on Sales for 15 consecutive years, with 0.11% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 10.0% to 0.11% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.09% through Dec 2025, down 1.0% year-over-year, with the annual reading at 0.09% for FY2025, 1.0% down from the prior year.
  • Return on Sales for Q4 2025 was 0.11% at Marimed, down from 0.07% in the prior quarter.
  • The five-year high for Return on Sales was 0.23% in Q2 2021, with the low at 0.26% in Q4 2023.
  • Average Return on Sales over 5 years is 0.02%, with a median of 0.03% recorded in 2023.
  • Peak annual rise in Return on Sales hit 49bps in 2021, while the deepest fall reached -51bps in 2021.
  • Over 5 years, Return on Sales stood at 0.21% in 2021, then skyrocketed by 164bps to 0.13% in 2022, then plummeted by -296bps to 0.26% in 2023, then increased by 19bps to 0.21% in 2024, then soared by 47bps to 0.11% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.11%, 0.07%, and 0.03% for Q4 2025, Q3 2025, and Q2 2025 respectively.